Gallagher C - Search Results

1

Does the rapid response to cisplatin-based chemotherapy justify its use as primary treatment for intracranial germ-cell tumours?

Vijayaraghavan S, Brock C, Monson JP, Snodgrass GJ, King TT, Gallagher C, Oliver RT. Vijayaraghavan S, et al. Among authors: gallagher c. Q J Med. 1993 Dec;86(12):801-10. Q J Med. 1993. PMID: 7509079

2

Pilot study to evaluate impact of a policy of adjuvant chemotherapy for high risk stage 1 malignant teratoma on overall relapse rate of stage 1 cancer patients.

Oliver RT, Raja MA, Ong J, Gallagher CJ. Oliver RT, et al. Among authors: gallagher cj. J Urol. 1992 Nov;148(5):1453-5; discussion 1455-6. doi: 10.1016/s0022-5347(17)36937-9. J Urol. 1992. PMID: 1279211

3

Accelerated cisplatin-based chemotherapy for advanced bladder cancer.

Boshoff C, Oliver RT, Gallagher CJ, Ong J. Boshoff C, et al. Among authors: gallagher cj. Eur J Cancer. 1995 Sep;31A(10):1633-6. doi: 10.1016/0959-8049(95)00201-s. Eur J Cancer. 1995. PMID: 7488414 Clinical Trial.

4

Prebiopsy neo-adjuvant endocrine therapy for breast cancer to prevent post-surgery trauma-induced growth factor and immune-suppression mediated tumour progression.

Oliver RT, Tobias J, Gallagher C. Oliver RT, et al. Among authors: gallagher c. Eur J Cancer. 1996 Mar;32A(3):396-7. doi: 10.1016/0959-8049(95)00589-7. Eur J Cancer. 1996. PMID: 8814680 Review. No abstract available.

5

Castration-induced lymphocytosis in prostate cancer: possible evidence for gonad/thymus endocrine interaction in man.

Oliver RT, Joseph JV, Gallagher CJ. Oliver RT, et al. Among authors: gallagher cj. Urol Int. 1995;54(4):226-9. doi: 10.1159/000282729. Urol Int. 1995. PMID: 7610506 Clinical Trial.

6

Intermittent endocrine therapy and its potential for chemoprevention of prostate cancer.

Oliver RT, Gallagher CJ. Oliver RT, et al. Among authors: gallagher cj. Cancer Surv. 1995;23:191-207. Cancer Surv. 1995. PMID: 7621458 Review.

7

Sixty percent salvage rate for germ-cell tumours using sequential m-BOP, surgery and ifosfamide-based chemotherapy.

Shamash J, Oliver RT, Ong J, Raja M, Edmonds P, Gallagher CJ, Ostrowski MJ, LeVay J, Williams M. Shamash J, et al. Among authors: gallagher cj. Ann Oncol. 1999 Jun;10(6):685-92. doi: 10.1023/a:1008318612005. Ann Oncol. 1999. PMID: 10442191 Free article.

8

Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma.

Mulatero C, McClaren BR, Mason M, Oliver RT, Gallagher CJ. Mulatero C, et al. Among authors: gallagher cj. Br J Cancer. 2000 Dec;83(12):1612-6. doi: 10.1054/bjoc.2000.1480. Br J Cancer. 2000. PMID: 11104554 Free PMC article. Clinical Trial.

9

Should high-dose chemotherapy be used to consolidate second or third line treatment in relapsing germ cell tumours?

Shamash J, O'Doherty CA, Oliver RT, Kelsey S, Gupta RK, Gallagher CJ, Newland AC, Lister TA. Shamash J, et al. Among authors: gallagher cj. Acta Oncol. 2000;39(7):857-63. doi: 10.1080/028418600750063622. Acta Oncol. 2000. PMID: 11145445 Clinical Trial.

10

Phase I study comparing continuous infusion of recombinant interleukin-2 by subcutaneous or intravenous administration.

Leahy MG, Pitfield D, Popert S, Gallagher CJ, Oliver RT. Leahy MG, et al. Among authors: gallagher cj. Eur J Cancer. 1992;28A(6-7):1049-51. doi: 10.1016/0959-8049(92)90453-9. Eur J Cancer. 1992. PMID: 1627372 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,115 results

Search Page

Filters